Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingkun Ma

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Journal of Medicinal Chemistry|July 19, 2024
Discovery of a Highly Potent, Selective and Efficacious USP7 Degrader for the Treatment of Acute Lymphoblastic LeukemiaMiaomiao Xu, Jingfeng Fu, Yuan Pei, et al.
Acta Pharmaceutica Sinica. B|March 5, 2025
DiPTAC: A degradation platform <i>via</i> directly targeting proteasomeYutong Tu, Qian Yu, Mengna Li, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Journal of Medicinal Chemistry|July 19, 2024
Discovery of a Highly Potent, Selective and Efficacious USP7 Degrader for the Treatment of Acute Lymphoblastic LeukemiaMiaomiao Xu, Jingfeng Fu, Yuan Pei, et al.
Acta Pharmaceutica Sinica. B|March 5, 2025
DiPTAC: A degradation platform <i>via</i> directly targeting proteasomeYutong Tu, Qian Yu, Mengna Li, et al.
Pageof 2